Nifty

:

23349.90

Sensex

:

77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Login

Nifty
Sensex

:
:

23349.90
77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Suven Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 543064 | NSE: SUVENPHAR

Watchlist

NSE BSE

813.60

05-Jul-2024

Open
High
Low
Previous Close

821.05
821.05
804.30
814.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

217390
1762.55
1353.95
585.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

32,571.59
134.18
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

32,538.51
N/A
16.49

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
4.75
-7.31

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
1.07
-6.95

PAT CAGR (%)

10 Years
5 Years
3 Years

-
2.24
-12.86

P:E (Median)

8 Years
5 Years
3 Years

-
-
31.97

P:BV (Average)

8 Years
5 Years
3 Years

-
-
8.82

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
28.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 236.06 224.62 5.09% 222.09 344.03 -35.44% 243.52 364.39 -33.17% 212.83 348.49 -38.93%
Expenses 135.05 126.58 6.69% 139.05 173.36 -19.79% 171.38 186.99 -8.35% 144.69 201.42 -28.17%
EBITDA 101.01 98.04 3.03% 83.04 170.67 -51.34% 72.14 177.40 -59.33% 68.14 147.07 -53.67%
EBIDTM 42.79% 43.65% 37.39% 49.61% 29.62% 48.68% 32.02% 42.20%
Other Income 13.43 14.20 -5.42% 17.95 10.06 78.43% 16.87 10.75 56.93% 13.97 12.51 11.67%
Interest 1.47 1.14 28.95% 1.60 1.86 -13.98% 2.29 5.00 -54.20% 1.27 1.38 -7.97%
Depreciation 12.29 10.53 16.71% 12.00 11.22 6.95% 15.67 10.69 46.59% 11.33 10.91 3.85%
PBT 100.68 100.57 0.11% 87.39 167.65 -47.87% 71.05 172.47 -58.80% 69.50 147.28 -52.81%
Tax 24.35 25.84 -5.77% 22.31 43.35 -48.54% 17.62 42.30 -58.35% 17.14 37.82 -54.68%
PAT 76.33 74.73 2.14% 65.08 124.30 -47.64% 53.43 130.16 -58.95% 52.36 109.47 -52.17%
PATM 32.34% 33.27% 29.30% 36.13% 21.94% 35.72% 24.60% 31.41%
EPS 3.00 2.94 2.04% 2.56 4.88 -47.54% 2.10 5.11 -58.90% 2.06 4.30 -52.09%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 257.72 231.05 11.54% 230.69 347.55 -33.62% 252.93 369.36 -31.52% 219.82 353.77 -37.86%
Expenses 153.71 132.41 16.09% 150.76 179.80 -16.15% 179.59 197.49 -9.06% 154.68 207.08 -25.30%
EBITDA 104.01 98.64 5.44% 79.93 167.75 -52.35% 73.34 171.86 -57.33% 65.14 146.70 -55.60%
EBIDTM 40.36% 42.69% 34.65% 48.27% 29.00% 46.53% 29.64% 41.47%
Other Income 14.12 19.84 -28.83% 18.16 10.67 70.20% 17.05 11.40 49.56% 14.34 13.01 10.22%
Interest 1.67 1.14 46.49% 1.60 1.86 -13.98% 2.30 5.03 -54.27% 1.27 1.38 -7.97%
Depreciation 16.96 11.95 41.92% 13.40 12.61 6.26% 17.25 12.02 43.51% 12.75 12.24 4.17%
PBT 99.50 105.39 -5.59% 83.09 163.95 -49.32% 70.85 166.21 -57.37% 65.47 146.08 -55.18%
Tax 17.52 25.84 -32.20% 22.32 43.35 -48.51% 17.48 42.24 -58.62% 18.71 38.36 -51.23%
PAT 81.98 79.55 3.05% 60.77 120.60 -49.61% 53.37 123.97 -56.95% 46.75 107.72 -56.60%
PATM 31.81% 34.43% 26.34% 34.70% 21.10% 33.56% 21.27% 30.45%
EPS 3.23 3.12 3.53% 2.39 4.74 -49.58% 2.10 4.87 -56.88% 1.84 4.23 -56.50%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 914.50 1,024.99 1,330.08 1,320.22 1,009.72 833.79 377.83 Net Sales Growth -28.64% -22.94% 0.75% 30.75% 21.10% 120.68% Cost Of Goods Sold 249.93 298.62 394.26 394.05 297.56 225.32 101.46 Gross Profit 664.57 726.38 935.83 926.17 712.16 608.47 276.37 GP Margin 72.67% 70.87% 70.36% 70.15% 70.53% 72.98% 73.15% Total Expenditure 590.17 615.09 739.39 737.94 566.68 449.00 206.28 Power & Fuel Cost - 46.16 71.35 59.55 44.20 38.23 18.06 % Of Sales - 4.50% 5.36% 4.51% 4.38% 4.59% 4.78% Employee Cost - 126.88 108.58 100.48 76.23 65.10 29.63 % Of Sales - 12.38% 8.16% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 85.49 106.75 129.24 105.31 83.89 35.11 % Of Sales - 8.34% 8.03% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 32.97 31.13 28.43 27.69 25.93 12.62 % Of Sales - 3.22% 2.34% 2.15% 2.74% 3.11% 3.34% Selling & Distn. Exp. - 10.35 17.43 19.80 10.53 9.43 6.72 % Of Sales - 1.01% 1.31% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 14.63 9.90 6.37 5.16 1.08 2.69 % Of Sales - 1.43% 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 324.33 409.90 590.69 582.28 443.04 384.79 171.55 EBITDA Margin 35.47% 39.99% 44.41% 44.10% 43.88% 46.15% 45.40% Other Income 62.22 55.09 44.55 187.79 14.24 18.12 0.60 Interest 6.63 7.43 12.75 8.53 11.66 21.81 2.79 Depreciation 51.29 48.79 43.10 39.10 31.64 23.51 11.50 PBT 328.62 408.77 579.39 722.45 413.98 357.59 157.87 Tax 81.42 103.96 146.79 164.35 105.33 87.51 48.59 Tax Rate 24.78% 25.43% 25.34% 22.75% 25.44% 24.47% 30.78% PAT 247.20 304.82 432.60 558.10 308.65 270.08 109.27 PAT before Minority Interest 247.20 304.82 432.60 558.10 308.65 270.08 109.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 27.03% 29.74% 32.52% 42.27% 30.57% 32.39% 28.92% PAT Growth -43.65% -29.54% -22.49% 80.82% 14.28% 147.17% EPS 9.71 11.97 16.99 21.92 12.12 10.61 4.29

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 961.16 1,051.35 1,340.33 1,320.22 1,009.72 833.79 377.83 Net Sales Growth -26.16% -21.56% 1.52% 30.75% 21.10% 120.68% Cost Of Goods Sold 271.82 311.39 402.97 394.05 297.56 225.32 101.46 Gross Profit 689.34 739.97 937.36 926.17 712.16 608.47 276.37 GP Margin 71.72% 70.38% 69.94% 70.15% 70.53% 72.98% 73.15% Total Expenditure 638.74 645.54 766.17 738.50 566.72 449.03 206.28 Power & Fuel Cost - 48.30 73.93 59.55 44.20 38.23 18.06 % Of Sales - 4.59% 5.52% 4.51% 4.38% 4.59% 4.78% Employee Cost - 135.92 118.25 100.48 76.23 65.10 29.63 % Of Sales - 12.93% 8.82% 7.61% 7.55% 7.81% 7.84% Manufacturing Exp. - 89.05 109.62 129.24 105.31 83.89 35.11 % Of Sales - 8.47% 8.18% 9.79% 10.43% 10.06% 9.29% General & Admin Exp. - 35.90 33.87 28.99 27.73 25.97 12.62 % Of Sales - 3.41% 2.53% 2.20% 2.75% 3.11% 3.34% Selling & Distn. Exp. - 10.35 17.64 19.80 10.53 9.43 6.72 % Of Sales - 0.98% 1.32% 1.50% 1.04% 1.13% 1.78% Miscellaneous Exp. - 14.63 9.90 6.37 5.16 1.08 2.69 % Of Sales - 1.39% 0.74% 0.48% 0.51% 0.13% 0.71% EBITDA 322.42 405.81 574.16 581.72 443.00 384.76 171.55 EBITDA Margin 33.54% 38.60% 42.84% 44.06% 43.87% 46.15% 45.40% Other Income 63.67 61.91 46.36 92.38 14.24 18.12 0.60 Interest 6.84 7.45 12.81 8.53 11.67 23.07 2.79 Depreciation 60.36 54.60 47.99 39.10 31.64 23.51 11.50 PBT 318.91 405.67 559.73 626.48 413.94 356.30 157.87 Tax 76.03 105.39 148.44 213.78 105.33 87.51 48.59 Tax Rate 23.84% 25.98% 26.52% 34.12% 25.45% 24.56% 30.78% PAT 242.87 300.28 411.29 453.80 308.61 268.79 109.27 PAT before Minority Interest 243.10 300.28 411.29 453.80 308.61 268.79 109.27 Minority Interest 0.23 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 25.27% 28.56% 30.69% 34.37% 30.56% 32.24% 28.92% PAT Growth -43.76% -26.99% -9.37% 47.05% 14.81% 145.99% EPS 9.54 11.79 16.15 17.82 12.12 10.56 4.29

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 2,055.90 1,749.38 1,520.69 1,065.18 782.83 590.29 Share Capital 25.46 25.46 25.46 25.46 12.73 0.00 Total Reserves 2,028.45 1,723.92 1,495.24 1,039.73 770.10 577.56 Non-Current Liabilities 79.38 54.77 75.19 73.91 127.68 35.12 Secured Loans 0.00 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 10.01 7.87 8.89 6.65 8.31 5.95 Current Liabilities 203.58 298.50 346.23 321.49 319.85 190.67 Trade Payables 41.27 66.89 105.90 82.93 71.06 53.57 Other Current Liabilities 20.95 18.53 28.25 28.56 27.51 19.47 Short Term Borrowings 38.58 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 102.79 148.48 144.94 104.36 127.24 34.83 Total Liabilities 2,338.86 2,102.65 1,942.11 1,460.58 1,230.36 816.08 Net Block 523.54 512.03 534.19 441.16 356.74 270.90 Gross Block 764.20 713.00 693.81 569.62 456.66 347.41 Accumulated Depreciation 240.66 200.98 159.62 128.46 99.91 76.51 Non Current Assets 1,031.16 1,003.21 695.93 794.13 719.36 393.28 Capital Work in Progress 179.08 164.81 29.99 96.32 101.71 111.07 Non Current Investment 317.21 317.21 118.67 245.65 245.65 0.07 Long Term Loans & Adv. 11.33 9.16 13.07 10.85 15.06 11.02 Other Non Current Assets 0.00 0.00 0.00 0.16 0.20 0.22 Current Assets 1,307.69 1,099.44 1,246.19 666.45 511.00 422.80 Current Investments 767.45 392.85 481.22 180.59 30.67 7.06 Inventories 220.07 311.47 283.42 201.08 174.87 157.10 Sundry Debtors 126.97 109.66 236.37 102.38 117.20 147.50 Cash & Bank 21.58 46.23 32.95 9.56 13.96 12.90 Other Current Assets 171.63 10.73 9.15 56.03 174.30 98.24 Short Term Loans & Adv. 160.25 228.50 203.08 116.80 134.56 37.32 Net Current Assets 1,104.11 800.94 899.96 344.96 191.15 232.13 Total Assets 2,338.85 2,102.65 1,942.12 1,460.58 1,230.36 816.08

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 2,050.66 1,735.18 1,527.18 1,180.81 844.76 590.29 Share Capital 25.46 25.46 25.46 25.46 12.73 0.00 Total Reserves 2,023.21 1,709.73 1,501.72 1,155.35 832.03 577.56 Non-Current Liabilities 96.53 71.79 92.11 73.91 127.68 35.12 Secured Loans 0.00 4.56 28.44 35.59 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 91.25 0.00 Long Term Provisions 10.50 8.30 8.89 6.65 8.31 5.95 Current Liabilities 206.06 303.09 347.52 321.51 319.85 190.67 Trade Payables 42.36 70.09 105.90 82.93 71.06 53.57 Other Current Liabilities 21.22 19.84 29.54 28.57 27.51 19.47 Short Term Borrowings 38.58 64.60 67.13 105.64 94.04 82.79 Short Term Provisions 103.90 148.56 144.94 104.36 127.24 34.83 Total Liabilities 2,353.25 2,110.06 1,966.81 1,576.23 1,292.29 816.08 Net Block 669.62 663.33 534.19 441.16 356.74 270.90 Gross Block 927.38 875.60 693.81 569.62 456.66 347.41 Accumulated Depreciation 257.76 212.27 159.62 128.46 99.91 76.51 Non Current Assets 990.90 954.70 701.66 909.68 781.17 393.28 Capital Work in Progress 179.08 165.09 29.99 96.32 101.71 111.07 Non Current Investment 130.58 117.10 117.10 361.19 307.46 0.07 Long Term Loans & Adv. 11.41 9.19 13.07 10.85 15.06 11.02 Other Non Current Assets 0.20 0.00 7.30 0.16 0.20 0.22 Current Assets 1,362.35 1,155.37 1,265.16 666.54 511.12 422.80 Current Investments 773.90 418.94 481.22 180.59 30.67 7.06 Inventories 231.20 312.81 283.42 201.08 174.87 157.10 Sundry Debtors 133.66 110.94 236.37 102.38 117.20 147.50 Cash & Bank 50.50 68.01 47.31 9.65 14.07 12.90 Other Current Assets 173.09 11.46 9.15 56.03 174.30 98.24 Short Term Loans & Adv. 161.19 233.21 207.69 116.80 134.56 37.32 Net Current Assets 1,156.29 852.28 917.64 345.04 191.27 232.13 Total Assets 2,353.25 2,110.07 1,966.82 1,576.22 1,292.29 816.08

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 370.65 492.82 269.89 328.84 358.75 50.40 PBT 408.77 579.39 722.45 413.98 357.59 157.87 Adjustment 10.22 35.68 -110.18 36.48 33.35 13.93 Changes in Working Capital 60.17 23.53 -190.63 -12.19 54.22 -88.33 Cash after chg. in Working capital 479.17 638.61 421.64 438.27 445.16 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -108.52 -145.79 -151.74 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -381.58 -236.86 -90.30 -257.66 -366.65 -65.48 Net Fixed Assets -65.47 -154.01 -57.86 -107.57 -99.89 Net Investments -374.60 -110.17 -173.65 -149.92 -269.19 Others 58.49 27.32 141.21 -0.17 2.43 Cash from Financing Activity -13.78 -243.14 -156.48 -75.66 8.58 25.98 Net Cash Inflow / Outflow -24.71 12.81 23.12 -4.49 0.67 10.90 Opening Cash & Equivalents 43.02 30.21 7.09 11.58 10.90 0.00 Closing Cash & Equivalent 18.31 43.02 30.21 7.09 11.58 10.90

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 358.48 457.20 330.00 382.55 406.92 50.40 PBT 405.67 559.73 667.59 467.67 404.51 157.87 Adjustment 15.35 37.46 40.63 36.48 34.60 13.93 Changes in Working Capital 47.41 5.77 -193.97 -12.17 54.21 -88.33 Cash after chg. in Working capital 468.43 602.96 514.26 491.98 493.33 83.47 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -109.95 -145.76 -184.26 -109.44 -86.41 -33.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -362.25 -195.01 -136.14 -311.40 -413.45 -65.48 Net Fixed Assets -65.47 -154.01 -57.86 -107.57 -99.89 Net Investments -374.60 -110.17 -173.65 -149.92 -269.19 Others 77.82 69.17 95.37 -53.91 -44.37 Cash from Financing Activity -13.80 -241.95 -156.48 -75.66 7.32 25.98 Net Cash Inflow / Outflow -17.57 20.24 37.38 -4.51 0.79 10.90 Opening Cash & Equivalents 64.80 44.56 7.18 11.70 10.90 0.00 Closing Cash & Equivalent 47.23 64.80 44.56 7.18 11.70 10.90

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 80.68 68.72 59.74 41.84 30.75 0.00 ROA 13.73% 21.39% 32.80% 22.94% 26.40% 13.39% ROE 16.03% 26.46% 43.17% 33.40% 39.71% 18.92% ROCE 21.27% 34.48% 51.79% 39.15% 46.23% 23.87% Fixed Asset Turnover 1.39 1.89 2.09 1.97 2.07 1.09 Receivable days 42.13 47.44 46.80 39.69 57.94 142.49 Inventory Days 94.64 81.55 66.93 67.95 72.66 151.76 Payable days 66.10 79.99 87.45 94.44 49.88 86.75 Cash Conversion Cycle 70.67 49.01 26.27 13.19 80.72 207.50 Total Debt/Equity 0.02 0.04 0.06 0.13 0.24 0.14 Interest Cover 56.04 46.45 85.72 36.49 17.39 57.60

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 80.48 68.16 59.99 46.39 33.18 0.00 ROA 13.46% 20.18% 25.62% 21.52% 25.50% 13.39% ROE 15.87% 25.21% 33.52% 30.47% 37.80% 18.92% ROCE 21.22% 33.41% 45.92% 36.19% 44.55% 23.87% Fixed Asset Turnover 1.17 1.71 2.09 1.97 2.07 1.09 Receivable days 42.46 47.25 46.80 39.69 57.94 142.49 Inventory Days 94.43 81.11 66.93 67.95 72.66 151.76 Payable days 65.90 79.70 87.45 94.44 49.88 86.75 Cash Conversion Cycle 70.98 48.66 26.27 13.19 80.72 207.50 Total Debt/Equity 0.02 0.04 0.06 0.12 0.22 0.14 Interest Cover 55.44 44.69 79.29 36.48 16.45 57.60

Top Investors:

jasti property and equity holdings private limited

dsp healthcare fund

sbi life insurance co. ltd

uti small cap fund

goldman sachs funds - goldman sachs india equity p

hsbc small cap fund

invesco india manufacturing fund

tata nifty 500 multicap india manufacturing 50:30:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Suven Pharmaceuticals’ arm gets EIR from USFDA for manufacturing facility
9th Sep 2024, 18:00 PM

The US FDA has categorized the inspection as Voluntary Action Indicated
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback